Elite Health net loss widens to $1.53 million in Q2 2026; revenue turns positive to $1.47 million

• Elite Health Systems posted a GAAP net loss of $1.53 million in Q2 2026, widening from $441,000 a year earlier.
• Revenue totaled $1.47 million, including $162,000 of policy revenue from serving Medicare Advantage members and $1.31 million from services.
• Selling, general and administrative expense climbed to $1.71 million, up 149%, as it continued investing in the business.
• For the first six months, GAAP net loss widened to $2.83 million from $865,000, with revenue of $3.04 million.
• Board authorized a strategic review, including potential financing, asset sales, or a merger, as going-concern doubt was raised at June 30.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Elite Health Systems Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-028491), on August 19, 2026, and is solely responsible for the information contained therein.